Magnetar Financial’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Magnetar Financial’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-145,000	Closed	-$1.43K	–	1954
2022 Q2	$1.43K	Sell	145,000 -55,000	-28%	-$545K	0.01%	840
2022 Q1	$1.98M	Hold	200,000	–	–	0.02%	672
2021 Q4	$1.99M	Hold	200,000	–	–	0.02%	682
2021 Q3	$2M	Hold	200,000	–	–	0.02%	604
2021 Q2	$2.02K	Hold	200,000	–	–	0.02%	575
2021 Q1	$2.04M	Hold	200,000	–	–	0.02%	573
2020 Q4	$2.08M	Buy	+200,000	New	+$2.09M	0.03%	355

Other funds holding FLACU

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Magnetar Financial's FLACU Position: Q3 2022 in Review

Magnetar Financial sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q3 2022, closing a stake of 145,000 shares — an estimated $1.43K sold.

Magnetar Financial first reported a position in FLACU in Q4 2020 and held it in 7 quarters. The position peaked at $2.08M in Q4 2020. 14 funds tracked by Wall St. Rank hold FLACU as of Q3 2022.

Magnetar Financial reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q3 2022 after selling out during the quarter.
Magnetar Financial sold 145,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q3 2022, an estimated $1.43K.
Magnetar Financial first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 7 quarters.
Magnetar Financial's Frazier Lifesciences Acquisition Corporation Unit position peaked at $2.08M in Q4 2020.
14 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.